Headlands Research Expands California Footprint with Clinical Trials Research Acquisition
WEST PALM BEACH, Fla., and SACRAMENTO, Calif., June 30, 2026 Headlands Research announced the acquisition of Clinical Trials Research...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
WEST PALM BEACH, Fla., and SACRAMENTO, Calif., June 30, 2026 Headlands Research announced the acquisition of Clinical Trials Research...
BAAR, Switzerland, June 30, 2026 Novocure has achieved a significant milestone in cancer treatment with the CE Mark approval...
CARY, N.C., June 30, 2026 Allucent, a global specialty Contract Research Organization (CRO) serving small and mid-sized biopharmaceutical companies,...
CHICAGO, Ill., June 20, 2026 Avance Clinical, a leading global Contract Research Organization (CRO) specializing in accelerating clinical development...
WALNUT CREEK, Calif., and BEIJING, China, May 11, 2026 Dark Horse Consulting Group (DHCG) and KunTuo Medical Research and...
CAMBRIDGE, Massachusetts, April 2026 Iterative Health announced the successful close of a $77 million Series C funding round, reinforcing...
WALTHAM, Massachusetts, USA, April 28, 2026 Thermo Fisher Scientific has announced the opening of its flagship U.S. Bioprocess Design...
Raleigh, North Carolina | April 13, 2026 Endpoint Clinical has announced the release of Elosity® R3, a major upgrade...
